HomeNewsWorldJapan imposes 'emergency' measures against virus

Japan imposes 'emergency' measures against virus

Those requiring hospitalization grew to more than 168,000 people, and complaints have surfaced about hospitals turning patients away.

August 20, 2021 / 09:38 IST
Story continues below Advertisement
Rank 3 | Japan | 2020 brand value: $ billion | Fall in brand value: 6 percent (Image: Reuters)
Rank 3 | Japan | 2020 brand value: $ billion | Fall in brand value: 6 percent (Image: Reuters)

Much of Japan kicked in its government “state of emergency” to curb COVID-19 infections Friday, as well as a less stringent “quasi-emergency,” although worries remained about their effectiveness.

Those requiring hospitalization grew to more than 168,000 people, and complaints have surfaced about hospitals turning patients away.

Story continues below Advertisement

The emergency, which lasts through Sept. 12, requests restaurants and bars to close at 8 p.m. and not serve alcohol, and shopping malls to limit crowd size.

New daily COVID-19 cases totaled 25,146 people nationwide, averaging 20,307 a day this week, up from 14,729 last week, the Health Ministry said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show